Literature DB >> 8436340

Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma.

F Pezzella1, H Morrison, M Jones, K C Gatter, D Lane, A L Harris, D Y Mason.   

Abstract

We have investigated the immunohistochemical expression of p53 protein in 96 cases of non-Hodgkin's lymphoma using a panel of five antibodies. Positive neoplastic cells were found in 30 (31.2%) cases, which could be divided into two groups according to their patterns of reactivity with the different antibodies; i.e. those positive with both polyclonal and monoclonal antibodies, and those which were stained only by monoclonal antibodies PAb1801 and/or PAb240. Positivity was nuclear in all but six cases in which cytoplasmic staining was found. In view of the hypothesis recently raised that p53 protein induces apoptosis we have compared our results with parallel staining for bcl-2 protein since bcl-2 is believed to be important, at least in lymphomas, in suppression of apoptosis. Staining for bcl-2 protein was performed on 83 cases and it was shown that p53-positive cases accounted for 10 out of 17 (59%) of the bcl-2-negative lymphomas but only for 15 out of the 66 (23%) bcl-2-positive cases, suggesting a possible relationship between the expression of these two proteins. Thus, our data show that p53 protein is abnormally expressed in a substantial proportion of non-Hodgkin's lymphomas and bears a significant inverse relationship to bcl-2 protein expression. However the molecular basis of this expression remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436340     DOI: 10.1111/j.1365-2559.1993.tb00067.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

1.  Expression of bcl-2 Protein in Breast Carcinoma with Correlation to Expression of p53 Protein and Clinicopathological Factors.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas.

Authors:  N Kapucuoglu; L Losi; V Eusebi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.

Authors:  C Kouvidou; P Kanavaros; D Papaioannou; E Stathopoulos; F Sotsiou; G Datseris; M Tzardi; C Kittas; G Delides
Journal:  Clin Mol Pathol       Date:  1995-02

4.  p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.

Authors:  M Tzardi; C Kouvidou; I Panayiotides; K Stefanaki; D Rontogianni; E Zois; K Koutsoubi; G Eliopoulos; G Delides; P Kanavaros
Journal:  Clin Mol Pathol       Date:  1996-10

5.  bcl-2 protein in invasive ductal breast carcinomas.

Authors:  J Hurlimann; B Larrinaga; D L Vala
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice.

Authors:  G Li; D L Mitchell; V C Ho; J C Reed; V A Tron
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Bcl-2 protein expression and long-term survival in breast cancer.

Authors:  H Joensuu; L Pylkkänen; S Toikkanen
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

Authors:  A Y Matsushima; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

9.  Apoptosis and Expression of the Proto-Oncogenes bcl-2 and p53 and the Proliferation Factor Ki-67 in Human Medullary Thyroid Carcinoma.

Authors:  Wenliang Wang; Henry Johansson; Ulla Bergholm; Erik Wilander; Lars Grimelius
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status.

Authors:  C Doglioni; A P Dei Tos; L Laurino; C Chiarelli; M Barbareschi; G Viale
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.